In	B:C1515655
vivo	I:C1515655
genome	B:C4279981
editing	I:C4279981
via	O
clustered	B:C1513384
regularly	I:C1513384
interspaced	I:C1513384
short	I:C1513384
palindromic	I:C1513384
repeat	I:C1513384
/	I:C1513384
Cas9	I:C1513384
mediated	O
homology	B:C1513384
-	I:C1513384
independent	I:C1513384
targeted	I:C1513384
integration	I:C1513384
.	O

Targeted	O
genome	B:C4279981
editing	I:C4279981
via	O
engineered	B:C0017387
nucleases	B:C0597094
is	O
an	O
exciting	O
area	O
of	O
biomedical	B:C0005540
research	I:C0005540
and	O
holds	O
potential	O
for	O
clinical	O
applications	O
.	O

Despite	O
rapid	O
advances	O
in	O
the	O
field	O
,	O
in	B:C1515655
vivo	I:C1515655
targeted	B:C1158478
transgene	I:C1158478
integration	I:C1158478
is	O
still	O
infeasible	O
because	O
current	O
tools	B:C4279981
are	O
inefficient	O
,	O
especially	O
for	O
non-dividing	B:C1512899
cells	I:C1512899
,	O
which	O
compose	O
most	O
adult	O
tissues	B:C0040300
.	O

This	O
poses	O
a	O
barrier	O
for	O
uncovering	O
fundamental	O
biological	O
principles	O
and	O
developing	O
treatments	B:C0087111
for	O
a	O
broad	O
range	O
of	O
genetic	B:C0019247
disorders	I:C0019247
.	O

Based	O
on	O
clustered	B:C1513384
regularly	I:C1513384
interspaced	I:C1513384
short	I:C1513384
palindromic	I:C1513384
repeat	I:C1513384
/	I:C1513384
Cas9	I:C1513384
(	I:C1513384
CRISPR	I:C1513384
/	I:C1513384
Cas9	I:C1513384
)	I:C1513384
technology	I:C1513384
,	O
here	O
we	O
devise	O
a	O
homology	B:C1513384
-	I:C1513384
independent	I:C1513384
targeted	I:C1513384
integration	I:C1513384
(	I:C1513384
HITI	I:C1513384
)	I:C1513384
strategy	I:C1513384
,	O
which	O
allows	O
for	O
robust	O
DNA	B:C0012854
knock	B:C1517676
-	I:C1517676
in	I:C1517676
in	O
both	O
dividing	B:C0230517
and	O
non-dividing	B:C1512899
cells	I:C1512899
in	B:C3850137
vitro	I:C3850137
and	O
,	O
more	O
importantly	O
,	O
in	B:C1515655
vivo	I:C1515655
(	O
for	O
example	O
,	O
in	O
neurons	B:C0027882
of	O
postnatal	O
mammals	B:C0024660
)	O
.	O

As	O
a	O
proof	O
of	O
concept	O
of	O
its	O
therapeutic	O
potential	O
,	O
we	O
demonstrate	O
the	O
efficacy	O
of	O
homology	B:C1513384
-	I:C1513384
independent	I:C1513384
targeted	I:C1513384
integration	I:C1513384
in	O
improving	O
visual	B:C0042789
function	I:C0042789
using	O
a	O
rat	B:C0599779
model	I:C0599779
of	O
the	O
retinal	B:C0035304
degeneration	I:C0035304
condition	O
retinitis	B:C0035334
pigmentosa	I:C0035334
.	O

The	O
HITI	B:C1513384
method	I:C1513384
presented	O
here	O
establishes	O
new	O
avenues	O
for	O
basic	B:C0681833
research	I:C0681833
and	O
targeted	O
gene	B:C0017296
therapies	I:C0017296
.	O

